https://www.selleckchem.com/pr....oducts/enarodustat.h
logue and glucocorticoid didn't show efficiency in prevention of CRPF in high risk patients, although difference between subgroups wasn't statistically significant (p=0.34). In low risk group patients prophylactic use of somatostatin analogue also didn't show decline of CRPF incidence and the difference between subgroups also wasn't statistically significant (p=0.46). To compare functional outcomes of various rectal reconstruction after total mesorectal excision. A prospective randomized trial included 90 patients with mid-to-low re
Like
Comment
Share
